09/12/2025
CLINUVEL today announced a significant expansion of its VALLAURIX Research, Development and Innovation (RD&I) Centre in Singapore. This strategic five-year investment solidifies the site’s transition into a global hub for developing advanced, long-acting peptide formulations.
More details are available at: https://clinuvel.com/2025/12/clinuvel-expands-singapore-rdi-centre-to-pioneer-next-generation-peptide-therapies-20251208/